• 1567 Citations
  • 19 h-Index
If you made any changes in Pure these will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the person's scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 64 Similar Profiles
Cost-Benefit Analysis Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Breast Neoplasms Medicine & Life Sciences
Costs and Cost Analysis Medicine & Life Sciences
Biomedical Technology Assessment Medicine & Life Sciences
Exercise Medicine & Life Sciences
Netherlands Medicine & Life Sciences
Quality-Adjusted Life Years Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1994 2018

Open Access
Mathematical programming
Radiation Therapy
Mathematical Programming
Programming Model
Open Access
Delivery of Health Care
Electronic Health Records

Benchmarking cancer centers: From care pathways to integrated practice units

Wind, A., Gonçalves, F. R., Marosi, E., Da Pieve, L., Groza, M., Asioli, M., Albini, M. & Van Harten, W. 1 Sep 2018 In : JNCCN Journal of the National Comprehensive Cancer Network. 16, 9, p. 1075-1083 9 p.

Research output: Contribution to journalArticle

Breast Neoplasms
1 Citations

Cost–utility and cost-effectiveness of physical exercise during adjuvant chemotherapy

van Waart, H., van Dongen, J. M., van Harten, W. H., Stuiver, M. M., Huijsmans, R., Hellendoorn-van Vreeswijk, J. A. J. H., Sonke, G. S. & Aaronson, N. K. Jul 2018 In : European journal of health economics. 19, 6, p. 893-904 12 p.

Research output: Contribution to journalArticle

Adjuvant Chemotherapy
Cost-Benefit Analysis
Costs and Cost Analysis

Early cost-effectiveness of tumor infiltrating lymphocytes (TIL) for second line treatment in advanced melanoma: a model-based economic evaluation

Retel, V. P., Steuten, L. M. G., Foppen, M. H. G., Mewes, J. C., Lindenberg, M. A., Haanen, J. B. A. G. & van Harten, W. H. 15 Sep 2018 In : BMC cancer. 18, 895

Research output: Contribution to journalArticle

Open Access

Activities 2009 2015

  • 2 Oral presentation

Alliantie Regionale Topzorg

van Harten, W. H. (Speaker)
4 Mar 2015

Activity: Oral presentation

Scenario drafting as a tool to perform early cost effectiveness analyses: the case of the 70-genes prognosis signature in breast cancer

Valesca P. Retèl (Speaker), Manuela Joore (Contributor), van Harten, W. H. (Contributor)
12 Jul 2009

Activity: Oral presentation